510(k) Report

PMA · Approved

Approved

Allurion™ Gastric Balloon System

P250023PMAApproved Feb 20, 2026235-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Allurion Technologies, Inc. · LTI Implant, Intragastric For Morbid Obesity

Approved on Feb 20, 2026 through premarket approval, which rests on the device’s own clinical evidence after a 235-day review.

Decided
Feb 20, 2026
Review
235 days
Class
Class III
Product code
LTI
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P250023 has 2 supplements since 2026: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2026: 2
2026high 2 (2026) · low 0 (2027)2027
View FIG. 1 as a table
YearSupplements approved
20262
FIG. 1 — Supplements to P250023, 2026–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LTI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LTI devices

LTI Implant, Intragastric For Morbid Obesity: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · LTI

2in 2025

2007: 22008: 52009: 42010: 72011: 102012: 12013: 22014: 32015: 62016: 142017: 142018: 322019: 212020: 52021: 32022: 22023: 42024: 42025: 22026 (partial year): 4
2007high 32 (2018) · low 1 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LTI

Too few LTI 510(k)s in any year since 2007 to give a median.

Recalls per year · LTI

1in 2016

2010: 172011: 12013: 32016: 1
2007high 17 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LTI

295in 2025

2007: 5872008: 1,3572009: 1,3652010: 1,4612011: 1,3472012: 1,3832013: 9202014: 5632015: 5602016: 5142017: 5282018: 4532019: 3342020: 1652021: 1932022: 6092023: 9752024: 4512025: 295
2007high 1,461 (2010) · low 165 (2020)2025

MAUDE reports naming product code LTI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—0587
20085—01,357
20094—01,365
20107—171,461
201110—11,347
20121—01,383
20132—3920
20143—0563
20156—0560
201614—1514
201714—0528
201832—0453
201921—0334
20205—0165
20213—0193
20222—0609
20234—0975
20244—0451
20252—0295
20264—0—
Cite this page

510(k) Report. “P250023: Allurion™ Gastric Balloon System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P250023

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026